StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report released on Sunday. The brokerage issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Trading Up 0.6 %
Brooklyn ImmunoTherapeutics stock opened at $1.78 on Friday. Brooklyn ImmunoTherapeutics has a 12 month low of $0.17 and a 12 month high of $10.10. The stock has a fifty day simple moving average of $2.11 and a two-hundred day simple moving average of $1.79. The firm has a market cap of $104.71 million, a price-to-earnings ratio of -0.78 and a beta of 4.61.
Brooklyn ImmunoTherapeutics Company Profile
Further Reading
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- Ride Out The Recession With These Dividend KingsĀ
- AMD is Down 35%. Now is the Time to Buy the Dip
- What Are Dividend Contenders? Investing in Dividend Contenders
- Amazon Stands Tall: New Highs Are in Sight
- What does consumer price index measure?
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.